- Report
- January 2022
- 40 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Japan
From €1426EUR$1,500USD£1,198GBP
In Vitro Diagnostics (IVD) is a medical specialty that involves the use of laboratory tests to diagnose and monitor diseases. IVD tests are used to detect, diagnose, and monitor a wide range of conditions, including infectious diseases, genetic disorders, and cancer. IVD tests are performed on samples taken from the body, such as blood, urine, and tissue.
The IVD market is a rapidly growing sector of the healthcare industry. It is estimated that the global IVD market will reach $90 billion by 2025. The market is driven by factors such as the increasing prevalence of chronic diseases, technological advancements, and the growing demand for personalized medicine.
The IVD market is divided into two segments: clinical diagnostics and point-of-care diagnostics. Clinical diagnostics are tests that are performed in a laboratory setting, while point-of-care diagnostics are tests that are performed at the patient's bedside.
Some of the major players in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more